2023
|
Invention
|
Substituted benzodiazoliums as enac inhibitors. 5 and X are as defined herein are inhibitors of t... |
2020
|
Invention
|
Compounds.
Compounds of general formula (I):
Compounds of general formula (I):
Compounds... |
|
Invention
|
Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions. Co... |
|
Invention
|
Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phneyl)acetyl]amino]pyridine-2-carboxamide. ... |
|
Invention
|
Pyridine derivatives as calcium-activated chloride channel modulators. Compounds of general formu... |
|
Invention
|
Solid forms of 4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-n-(1,1-dimethylprop-2-ynyl)pyridine... |
|
Invention
|
Crystalline form of 4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-n-cyclohexyl-pyridine-2-carbox... |
|
Invention
|
Compounds for treating respiratory disease. Compounds of general formula (I) and their tautomeric... |
2019
|
Invention
|
Compounds with activity as inhibitors of the epithelial sodium channel (enac). 4 and X are as def... |
|
Invention
|
Compounds. Compounds of general formula (I) wherein R1, R2, R3, R4 and X are as defined herein ar... |
|
Invention
|
Compounds. Compounds of general formula (I): wherein R1, R2, R3, R4, R5a, R5bX1, X2, Z and Y are ... |
2018
|
Invention
|
Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1h-1,3-benzod... |
2017
|
Invention
|
Benzodiazolium compounds as enac inhibitors. Compounds of general formula (I) wherein R1, R2, R3,... |
|
Invention
|
Compounds. − are as defined herein. The compounds are inhibitors of the epithelial sodium channel... |
|
Invention
|
Compounds. The invention relates to compounds of general formula (I): wherein R1, R2, R3, R10 and... |